Edition:
United Kingdom

Novelion Therapeutics Inc (NVLN.OQ)

NVLN.OQ on NASDAQ Stock Exchange Global Select Market

3.39USD
6:27pm GMT
Change (% chg)

$-0.02 (-0.59%)
Prev Close
$3.41
Open
$3.41
Day's High
$3.49
Day's Low
$3.36
Volume
4,685
Avg. Vol
23,115
52-wk High
$12.09
52-wk Low
$3.26

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Jason Aryeh

48 2012 Independent Chairman of the Board

Michael Price

59 2017 Chief Financial Officer, Senior Vice President

Gregory Perry

56 2016 Chief Financial and Administrative Officer

Jeffrey Hackman

55 2017 Chief Operating Officer, Executive Vice President

Barbara Chan

53 2016 Chief Accounting Officer